Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Related Keywords

,Our Public Health Solutions ,Us Congress ,Biomedical Advanced Research ,Development Authority ,Soligenix Inc ,Exchange Commission ,Defense Threat Reduction Agency ,Twitter ,Us Development ,Prnewswire Soligenix Inc ,Linkedin ,National Institute Of Allergy ,Nasdaq ,Annual Meeting ,Public Health Solutions ,National Institute ,Infectious Diseases ,Project Bioshield ,Priority Review Voucher ,